1 man brain dead, 5 others hospitalized in French drug trial
Because Phase I trials are used to determine a drug’s toxic effects, they “are inherently risky, as unexpected events can – and do – occur”, Carl Heneghan, a professor of evidence-based medicine at the University of Oxford, said in a statement.
Posted On Jan 17 2016